Cancer genetic testing in marginalized groups during an era of evolving healthcare reform
- PMID: 35559905
- PMCID: PMC8224823
- DOI: 10.1016/j.jcpo.2021.100275
Cancer genetic testing in marginalized groups during an era of evolving healthcare reform
Abstract
Background: The Affordable Care Act and subsequent reforms pose tradeoffs for racial-ethnic, rural, and sex-related groups in the United States experiencing disparities in BRCA1/2 genetic counseling and testing and colorectal cancer screening, calling for policy changes.
Methods: A working group of the American Public Health Association Genomics Forum Policy Committee engaged in monthly meetings to examine ongoing literature and identify policy alternatives in the coverage of cancer genetic services for marginalized groups. 589 items were collected; 408 examined. Efforts continued from February 2015 through September 2020.
Results: African Americans and Latinos have shown 7-8 % drops in uninsured rates since the Exchanges opened. The ACA has increased BRCA1/2 test availability while several disparities remain, including by sex. Rural testing and screening utilization rates have improved. Medicaid expansion and the inclusion of Medicare in the ACA have resulted in mixed improvements in colorectal cancer screening rates in marginalized groups.
Conclusion: Cancer genetic testing and screening to date have only partially benefited from healthcare reforms. Sensitivity to cost concerns and further monitoring of emerging data are needed. A reduction in disparities depends on the availability of private insurance, Medicaid and Medicare to the marginalized. Attention to value-based design and the way cancer benefits are translated into actual testing and screening are crucial.
Policy summary: The findings suggest the need for further benefits-related health agency interpretation of and amendments to the ACA, continued Medicaid and innovative Medicare expansion, and incorporation of cancer services values-based considerations at several levels, aimed at reducing group disparities.
Keywords: African Americans; Breast cancer; Colorectal cancer; Early detection of cancer; Genetic testing; Health care reform; Hispanic Americans; Rural population; Sex.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest
No competing financial interests exist.
Similar articles
-
Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.Healthcare (Basel). 2022 Jun 8;10(6):1066. doi: 10.3390/healthcare10061066. Healthcare (Basel). 2022. PMID: 35742117 Free PMC article. Review.
-
The three-year impact of the Affordable Care Act on disparities in insurance coverage.Health Serv Res. 2019 Feb;54 Suppl 1(Suppl 1):307-316. doi: 10.1111/1475-6773.13077. Epub 2018 Oct 30. Health Serv Res. 2019. PMID: 30378119 Free PMC article.
-
The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males.PLoS One. 2020 Jan 24;15(1):e0226942. doi: 10.1371/journal.pone.0226942. eCollection 2020. PLoS One. 2020. PMID: 31978084 Free PMC article.
-
Surveillance for Health Care Access and Health Services Use, Adults Aged 18-64 Years - Behavioral Risk Factor Surveillance System, United States, 2014.MMWR Surveill Summ. 2017 Feb 24;66(7):1-42. doi: 10.15585/mmwr.ss6607a1. MMWR Surveill Summ. 2017. PMID: 28231239 Free PMC article.
-
A Critical Analysis of Obamacare: Affordable Care or Insurance for Many and Coverage for Few?Pain Physician. 2017 Mar;20(3):111-138. Pain Physician. 2017. PMID: 28339427 Review.
Cited by
-
Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries.J Community Genet. 2024 Dec;15(6):681-686. doi: 10.1007/s12687-024-00744-5. Epub 2024 Oct 14. J Community Genet. 2024. PMID: 39397225 Free PMC article.
-
Predictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center.Gynecol Oncol. 2024 Jul;186:53-60. doi: 10.1016/j.ygyno.2024.03.028. Epub 2024 Apr 9. Gynecol Oncol. 2024. PMID: 38599112 Free PMC article.
-
Are beliefs about the importance of genetics for cancer prevention and early detection associated with high risk cancer genetic testing in the U.S. Population?Prev Med Rep. 2022 Mar 29;27:101781. doi: 10.1016/j.pmedr.2022.101781. eCollection 2022 Jun. Prev Med Rep. 2022. PMID: 35378849 Free PMC article.
-
Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.Healthcare (Basel). 2022 Jun 8;10(6):1066. doi: 10.3390/healthcare10061066. Healthcare (Basel). 2022. PMID: 35742117 Free PMC article. Review.
-
Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018.Hered Cancer Clin Pract. 2022 May 23;20(1):19. doi: 10.1186/s13053-022-00226-0. Hered Cancer Clin Pract. 2022. PMID: 35606835 Free PMC article.
References
-
- Chokshi N, Historians Take Note: What America Looked Like Before Obamacare [Accessed January 16, 2020];March 26, Washington Post, 2014, http://www.washingtonpost.com/blogs/govbeat/wp/2014/03/26/historians-tak....
-
- Moonesinghe R, Zhu J, Truman BI, Health insurance coverage – United States, 2004 and 2008, MMWR 60 (1 Suppl) (2011) 35–37. - PubMed
-
- Patient Protection and Affordable Care Act, Pub Law 111–148, 124 Stat 119–111th U.S. Congress, 2010.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous